Novel Coronavirus (SARS-CoV-2/COVID-19)

The incredible job that hospitals and caregivers have done over the past year saving lives, treating very sick patients and protecting their communities has been acknowledged and enabled by Congress through relief aid several times since the onset of the COVID-19 pandemic. 
The major Headlines, US Snapshots, US Vaccinations, US Variant Cases, key Highlights, as well as key Statistics, Vaccine and Treatment information, US Restrictions and the Back to Normal Index related to the novel coronavirus pandemic.
For the first time, the Food and Drug Administration authorized marketing a SARS-CoV-2 diagnostic test beyond the public health emergency based on additional data. FDA previously authorized the BioFire Respiratory Panel 2.1 test for emergency use to detect SARS-CoV-2 and other respiratory pathogens…
The Centers for Disease Control and Prevention has created a federal classification scheme for SARS-CoV-2 variants and posted information on their prevalence in the United States.
On this AHA Advancing Health podcast, Esther Corpuz, CEO of Alivio Medical Center in Chicago, talks about combating the COVID-19 pandemic through testing, vaccinations and education within the community.
The Food and Drug Administration launched a dashboard that will provide weekly updates on adverse events submitted to its adverse event reporting system for COVID-19 drugs and biological products authorized for emergency use.
The Centers for Disease Control and Prevention allocated $10 billion to states and territories from the American Rescue Plan Act to support testing to screen teachers, staff and students for COVID-19 to help reopen schools.
AHA letter to Senators, John Thune, Rob Portman, Shelley Moore Capito, Tammy Baldwin, Debbie Stabenow and Ben Cardin expressing support for legislation, S. 773.